Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The SURPASS-4 clinical trial was a non-inferiority study comparing tirzepatide to insulin glargine where tirzepartide showed superior A1c and body weight reductions from baseline in adults with T2DM at increased CVD risk.[20] Also, tirzepatide reported a higher occurrence of individuals achieving an A1c below 7% compared to insulin glargine
Hypoglycemia (low blood sugar) can be just as problematic as hyperglycemia (elevated blood sugar)
It is important to consult a healthcare provider to know the right dosage recommendations that work best for you
Only medications prescribed by a health-care professional and sold from licensed pharmacies should be used, it says
US$ 29.03
US$ 29.44
US$ 29.80
US$ 22.21
